EMD – innovative, specialized, international

The Merck Logo in front the pyramide and building B4 in the background.
In North America, Merck, Darmstadt, Germany operates under the umbrella brand EMD, formed from the initials of Emanuel Merck, Darmstadt. The EMD Group is a global pharmaceutical and chemical enterprise with approximately 33,000 employees in over 60 countries and total revenues of around € 7.6 billion (2008). The Pharmaceuticals business sector comprises innovative prescription drugs as well as over-the-counter products. The Chemicals business sector offers specialty products for the electronics, printing, coatings, cosmetics, pharmaceutical and biotech industries.
The operational business is managed under the umbrella of Merck KGaA headquartered in Darmstadt, Germany. Around 30% of the company’s total capital is publicly traded, while the Merck family owns an interest of about 70% via the general partner E. Merck OHG.
Merck in Darmstadt is the world’s oldest pharmaceutical and chemical company – its roots date back to 1668.
 
The most important therapeutic / application areas of EMD products
Pharmaceuticals
EMD Serono:Oncology, neurodegenerative diseases, fertility, endocrinology, autoimmune and inflammatory diseases, CardioMetabolic Care
Consumer Health Care:Everyday health protection, mobility, women’s and children’s health, cough and cold
Chemicals
Liquid Crystals:Liquid crystals for displays in televisions, computers,
mobile phones and navigation systems
Performance & Life Science Chemicals:Effect pigments for the coatings, printing and cosmetics industries, cosmetic actives, analytical reagents, test kits, products and services for the pharmaceutical and biotech industries